Antonio Carmona
Biographic Data
| ID | 10018083 |
|---|---|
| NAME | Antonio Carmona |
| GIVEN NAMES | Antonio |
| FAMILY NAME | Carmona |
| SIGNATURE | CARMONA A |
| AFFILIATIONS | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Avenida Cataluña 21, 46020 Valencia, Spain |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2000 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe
Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…
Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of Gaia Case Definitions
Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Sa…
Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the Covid-19 Emergence
The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public-private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to wor…
Cuba
The concept of a new and consolidated world order has generated many a discussion about the role of states in the political economy of nations and in transitions from one state form to another. With all the apparent global changes that have occurred during the 1990s, especially the demise of the Council for Mutual Economic Assistance (CMEA), a Sovietstyle parallel market system, the case of Cuba cannot be ignored. Most literature pertaining to th…
No prominent works on this page.
Cuba
The concept of a new and consolidated world order has generated many a discussion about the role of states in the political economy of nations and in transitions from one state form to another. With all the apparent global changes that have occurred during the 1990s, especially the demise of the Council for Mutual Economic Assistance (CMEA), a Sovietstyle parallel market system, the case of Cuba cannot be ignored. Most literature pertaining to th…
Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the Covid-19 Emergence
The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public-private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to wor…
Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of Gaia Case Definitions
Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Sa…
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe
Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…
Medicine (3 works) · Population (3 works) · Vaccine Coverage and Hesitancy (3 works) · Cohort (2 works) · Demography (2 works) · Environmental health (2 works) · Influenza vaccine (2 works) · Influenza Virus Research Studies (2 works) · Nursing (2 works) · Public health (2 works)